FDA Approved: EGATEN — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for EGATEN (triclabendazole) from Novartis Pharmaceuticals Corporation. The action approves a supplement to the orig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fascioliasis

Drugs mentioned

• Egaten (triclabendazole)

Snippet

SUPPL AP for EGATEN (TRICLABENDAZOLE)